Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. [electronic resource]
Producer: 20150414Description: 1431-8 p. digitalISSN:- 1592-8721
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- blood
- Bone Marrow -- drug effects
- Enzyme-Linked Immunosorbent Assay
- Female
- Follow-Up Studies
- Humans
- Lymphoma, Follicular -- drug therapy
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Neoplasm Recurrence, Local -- drug therapy
- Pilot Projects
- Prognosis
- Prospective Studies
- Remission Induction
- Rituximab
- Sex Factors
- Survival Rate
- Tissue Distribution
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.